Açıklama.

Image 1

We are proud of creating value in our high-capacity integrated production facility with the understanding of domestic and national production by adhering to the principle of "Service to the Homeland is Our Obligation".

Image 2
Image 1

Kalite standartlarından ödün vermeden uzman olduğumuz her alanda katma değeri yüksek ürünlere yönelik yatırım tesisleri kurmaktan gurur duyuyoruz.

Image 2
Image 1

We are proud to serve our country with a strong R&D and quality production approach in accordance with European norms, cGMP and cGLP regulations.

Image 2

Production facility

TRILC AT BORSA ISTANBUL

TURK Pharmaceuticals and Serum Industry, which had its public offering in 2021, offers its investors the opportunity for stable growth with its product range in the field of healthcare through technology transfer and as the highest volume serum production facility in our country. A young and dynamic company that offers investment opportunities in the healthcare field of Turkey, which has high growth potential.

OUR PRODUCTION FACILITY

TURK İlaç ve Serum Sanayi Anonim Şirketi is Turkey's highest capacity IV Parenteral Solution (Serum) production facility. Our company is the largest supplier of the Republic of Turkey. Our company produces IV Parenteral Solution and Ampoule/Vial group products. It has an annual production capacity of 120 million IV Parenteral Solutions (Serum), 160 million Ampoule/Vial products and 15 million Dialysis Solutions.

OUR UNDERSTANDING OF PRODUCTION

While our company invests in foreign exchange-generating activities by paying attention to the production of value-added products, it serves our country with the hope of establishing new partnerships for the industrialization of our country, creating value through commercial relations, opening employment areas, and contributing to the strengthening of the economy.

Türk İlaç is a global Turkish company.

Our Media & News